Subset of Colorectal Cancer Linked with Obesity, Physical Activity

Obesity, Physical Activity Linked to Risk in Subset of Colorectal CA
Obesity, Physical Activity Linked to Risk in Subset of Colorectal CA

(HealthDay News) -- Obesity and physical inactivity are associated with a higher risk of WNT/β-catenin (CTNNB1)-negative colorectal cancer, but are not associated with CTNNB1-positive cancer risk, according to a study published online Feb. 26 in Cancer Research.

To examine whether tumor CTNNB1 status influences cellular sensitivity to obesity and physical activity, Teppei Morikawa, M.D., Ph.D., from the Dana-Farber Cancer Institute in Boston, and colleagues used tissue immunohistochemistry data on nuclear CTNNB1 expression from 861 incident rectal and colon cancers identified during follow-up of 109,046 women in the Nurses' Health Study and 47,684 men in the Health Professionals Follow-up Study.

The researchers found that greater body mass index correlated with a significantly elevated risk of CTNNB1-negative cancer (multivariate hazard ratio [HR], 1.34 for 5.0 kg/m2 increment; Ptrend = 0.0001) but not with the risk of CTNNB1-positive cancer (multivariate HR, 1.07 for 5.0 kg/m2 increment; Ptrend = 0.36). There was a significantly lower risk of CTNNB1-negative cancer with higher physical activity levels (multivariate HR, 0.93 for 10 metabolic equivalent task [MET]-hours/week increment; Ptrend = 0.044) but no association with CTNNB1-positive cancer risk (multivariate HR, 0.98 for 10 MET-hours/week increment; Ptrend = 0.60).

"These data suggest that energy balance status exerts its effect in a specific carcinogenic pathway that is less likely dependent on WNT/ CTNNB1 activation," write the authors. "In the future, we may be able to identify individuals who are susceptible to the development of CTNNB1-negative tumors, and lifestyle preventive measures can be taken."

Abstract
Full Text (subscription or payment may be required)

This article originally appeared here.

Related Resources

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs

More in Gastrointestinal Cancers

Combating Colon Cancer Based on Genetic Mutations

Combating Colon Cancer Based on Genetic Mutations

Targeted therapy based on genetic mutations may soon become the standard of care for colorectal cancer.

Intervention Didn't Increase Colon Cancer Screening in PCPs

Intervention Didn't Increase Colon Cancer Screening in PCPs

Implementing a quality improvement intervention at a primary care practice is not necessarily linked to improved colon cancer screening.

Full-Spectrum Endoscopy Increases Polyp, Adenoma Detection

Full-Spectrum Endoscopy Increases Polyp, Adenoma Detection

Polyp and adenoma detection rates increased with lower miss rates when using full-spectrum endoscopy colonoscope instead of traditional forward-viewing colonoscope.